Recruiting healthy volunteers as well as those living with Alzheimer’s disease can be challenging. Now, a panel of experts has issued recommendations to improve recruitment efforts. Click here to read the full article. The post Recruiting people to participate in...
News
Expert panel recommends ways to aid recruitment for Alzheimers studies | Banner Health
A high-level panel of experts has issued recommendations to accelerate recruitment for Alzheimer’s disease clinical trials. There is growing urgency to increase awareness and recruitment for studies on Alzheimer’s disease, many of which need to enroll healthy...
World Alzheimer’s Day: Research and Support for Patients and Caregivers | Fox 10 AZAM
On “AZAM Arizona Morning”, David Weidman, MD (Banner Alzheimer’s Institute) discusses Alzheimer’s research and groundbreaking work by the Arizona Alzheimer’s Consortium. Courtesy Fox 10, September 21, 2022. The post World Alzheimer’s Day: Research and Support for...
Alzheimer’s conference at ASU to highlight advances in fight against disease | ASU News
The Arizona Alzheimer’s Consortium Conference, which brings together some of the nation’s top scientists and physicians to discuss advances in the fight against Alzheimer’s disease, will be held Sept. 22 at Arizona State University’s Tempe campus. The one-day...
Workshop introduces high school students to Alzheimer’s research | ASU News
In December 2021, the center received a $15.7 million NIH grant, which included support for the development of a pathway for students from diverse backgrounds to learn about Alzheimer’s disease research and care. Eric Reiman, MD, executive director of the Banner...
ASU Researchers Collaborate with Artists to Create Pieces Representing Work with Dementia Patients.
In the Artist + Researcher Exhibition, the first project to come out of the recently formed PBC Arts Committee, nine pairs of local artists and researchers from all three of the state’s public universities collaborated on visual art pieces that communicate some of the...
FDA Panel Declines to Endorse Alzheimer’s Drug — The New York Times
The drug, aducanumab, made by Biogen, would be the first new Alzheimer’s treatment in nearly two decades. But the advisory panel said there was not enough evidence of its effectiveness in slowing cognitive decline. Click here to read the full article from The New York...
Edson Family Commits $10 Million to Advance Specialty Memory Care Services at Banner Alzheimer’s Institute
Major charitable investment will offer new models of care for patients and families living with Alzheimer’s disease and other memory and thinking problems PHOENIX (September 22, 2020) – Banner Alzheimer’s Institute (BAI) has received a $10 million charitable...
Save the Date for the Arizona Wellbeing Commons 2020 Virtual Conference
Click here to register now!